Skip to main content
TipRanks
Go Ultimate75% OFF

Todd Christopher Longsworth Insider Profile

4 Followers

Todd Christopher Longsworth, General Counsel at NovoCure, holds 62.46K shares in NovoCure (Ticker: NVCR).

Todd Christopher Longsworth's Trading History

NVCR
NovoCure
Mar 09, 2022General CounselUninformative Sell163.96K$705.82K
NVCR
Insider Shares: 62.46K (0.00%)

Todd Christopher Longsworth has not reported any informative transactions for NVCR, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 09, 2022Uninformative Sell$163.96K2,339$70.10―
Mar 07, 2022Uninformative Sell$220.39K3,067$71.85―
Jul 08, 2021Uninformative Buy$21.12K154$137.12―
Mar 10, 2021Uninformative Sell$314.44K2,404$130.80―
Mar 08, 2021Uninformative Sell$424.20K3,084$137.55―

You May Also Like

Todd Christopher Longsworth insider profile FAQ

What stocks does Todd Christopher Longsworth hold?
Todd Christopher Longsworth holds: NVCR stocks.
What was Todd Christopher Longsworth’s latest transaction?
Todd Christopher Longsworth’s latest transaction was an Uninformative Sell of $163.96K.
What is Todd Christopher Longsworth's role in NovoCure?
Todd Christopher Longsworth's role in NovoCure is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.